SA
Go ProLog In
SLNO
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
12 analysts·Moderate coverage
67
Score
8 Buy (67%)4 Hold (33%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
867%
Hold
433%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$53.00
-0.0%
Consensus
$80.00
+50.9%
Bull
$107.00
+101.8%
12-Month Target Range12 analysts
$53.00$80.00$107.00
Current $53.01Consensus
Current Price
$53.01
Upside to Consensus
$26.99

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+50.86%
EPS+59.18%
FY2028
Rev+39.73%
EPS+37.99%
FY2029
Rev+29.87%
EPS+23.17%

Earnings Surprises

Recent Analyst Actions

Apr 17, 2026Wells Fargo
Soleno Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
Target:$53.00
+0.8%from $52.57
Mar 4, 2026H.C. Wainwright
Soleno Therapeutics Inc. (SLNO) PT Lowered to $100 at H.C. Wainwright
Target:$100.00
+159.8%from $38.49
Jan 20, 2026Wells Fargo
Soleno Therapeutics price target raised to $114 from $106 at Wells Fargo
Target:$114.00
+168.4%from $42.48
Jan 20, 2026H.C. Wainwright
Soleno Therapeutics price target raised to $120 from $110 at H.C. Wainwright
Target:$120.00
+182.5%from $42.48
Jan 13, 2026Robert W. Baird
Soleno Therapeutics price target lowered to $107 from $121 at Baird
Target:$107.00
+166.6%from $40.14
Jan 12, 2026Wolfe Research
Soleno Therapeutics price target lowered to $60 from $75 at Wolfe Research
Target:$60.00
+43.2%from $41.89
Nov 5, 2025Wells Fargo
Soleno Therapeutics price target lowered to $106 from $123 at Wells Fargo
Target:$106.00
+66.0%from $63.85
Oct 7, 2025Goldman Sachs
Soleno Therapeutics initiated with a Buy at Goldman Sachs
Target:$125.00
+113.9%from $58.45
Jul 11, 2025Robert W. Baird
Soleno Therapeutics price target raised to $121 from $105 at Baird
Target:$121.00
+48.3%from $81.57
Mar 28, 2025Guggenheim
Soleno Therapeutics price target raised to $81 from $70 at Guggenheim
Target:$81.00
+15.4%from $70.22
Mar 27, 2025Robert W. Baird
Soleno Therapeutics price target raised to $102 from $72 at Baird
Target:$102.00
+51.4%from $67.39
Mar 27, 2025UBS
Soleno Therapeutics price target raised to $105 from $75 at Laidlaw
Target:$105.00
+55.8%from $67.39
Dec 2, 2024H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)
Target:$70.00
+37.5%from $50.91
Oct 1, 2024Stifel Nicolaus
Soleno Therapeutics price target raised to $74 from $59 at Stifel
Target:$74.00
+46.6%from $50.49
Aug 27, 2024Stifel Nicolaus
Stifel Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)
Target:$59.00
+20.3%from $49.04
Aug 27, 2024Oppenheimer
Oppenheimer Reiterates Outperform Rating on Soleno Therapeutics Inc. (SLNO)
Target:$65.00
+39.0%from $46.76
May 23, 2024Piper Sandler
Piper Sandler Reiterates Overweight Rating on Soleno Therapeutics Inc. (SLNO)
Target:$93.00
+119.2%from $42.42
May 9, 2024Robert W. Baird
Baird Starts Soleno Therapeutics Inc. (SLNO) at Outperform
Target:$72.00
+51.1%from $47.64

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance